Press Releases

  • GUMC Launches Center for Global Health Science and Security
    September 30, 2016

    Georgetown University Medical Center announces the launch of the Center for Global Health Science and Security (GHSS) to conduct research to help build sustainable capacities to prevent, detect, and respond to public health emergencies worldwide. The GHSS is led by Rebecca Katz, PhD, MPH, and Julie Fischer, PhD.

  • Alzheimers
    Georgetown Receives FDA Clearance to Conduct Clinical Trial with Nilotinib in Alzheimer’s Disease
    September 29, 2016

    Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer’s disease.

  • New Clinical Trial Will Test Cancer Drug as Alzheimer's Treatment
    September 29, 2016

    The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna® for use as a cancer therapy) in patients with Alzheimer’s disease.

  • Researchers Say Research Needed on Effects of Cannabis on Human Development
    September 29, 2016

    In this new era of legalized marijuana, far too little research has been conducted on the effect of cannabis on the development of human embryos, say researchers at Georgetown University Medical Center who scoured medical literature on the topic and found what they say is worrisome animal research.

  • Study Questions Benefits of Testosterone Replacement for Low T
    September 21, 2016

    The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with “low T” is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials in PLOS One.

  • Math Difficulties May Reflect Problems in a Crucial Learning System in the Brain
    September 15, 2016

    Children differ substantially in their mathematical abilities. In fact, some children cannot routinely add or subtract, even after extensive schooling. Yet the causes of these problems are not fully understood. Now, two researchers, at Georgetown University Medical Center and Stanford University, have developed a theory of how developmental “math disability” occurs.

  • Tamoxifen Resistance Linked to High Estrogen Levels in Utero
    September 8, 2016

    WASHINGTON — An animal study suggests that resistance to tamoxifen therapy in some estrogen receptor positive breast cancers may originate from in utero exposure to endocrine disrupting chemicals. The study provides a new path forward in human research as about half of the breast cancers treated with this common cancer therapy do not respond well, say researchers at the Georgetown Lombardi Comprehensive Cancer Center, who led the multi-institutional research.

  • MEDIA ADVISORY: 2016 Ruesch Center Policy Briefing: Fighting a Smarter War on Cancer
    September 5, 2016

    WASHINGTON – The Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center hosts its 2016 Cancer Policy Briefing, Wednesday, September 14 from 9:00 to 11:30 a.m. at the Georgetown University Law Center.

  • Georgetown Medical Experts Available During Olympic Games
    August 5, 2016

    WASHINGTON -– Georgetown University Medical Center physicians and researchers are available to answer questions about medical topics related to athletes competing in the 2016 Olympic Games.

  • Collateral Harm: The Impact of Ebola and Related Fears on Facility-Based Child Deliveries
    August 2, 2016

    WASHINGTON -- The first known household survey examining the collateral harm to pregnancy services in areas affected by the West African Ebola epidemic suggests a significant slide backwards in child and maternal health. The study, conducted in Liberia, points to the deep disruptions caused by the Ebola epidemic — even in parts of the country with relatively limited transmission.